The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Regulatory News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

13 Nov 2013 16:33

RNS Number : 9668S
Amphion Innovations PLC
13 November 2013
 



 

Directors' DealingsDirectors Receive Shares in Lieu of Fees

London and New York, 13 November 2013- Amphion Innovations plc (the "Company") (LSE: AMP), the developer of medical and technology businesses, announces that the Company has today issued 663,821 ordinary shares, representing 0.45% of the enlarged issued share capital, to certain of its Board members as their directors' fees for the fourth quarter of 2012 and the first three quarters of 2013, priced at 4.175 pence, being the average of the closing mid-market price for the five days leading up to the market close on 12 November 2013.Following this issue, the directors' shareholdings in the Company are as follows:

Director

Number of New Shares

Total Shareholding

Percentage of voting rights

R. James Macaleer

501,321

24,480,266

16.666%

Gerard Moufflet

162,500

862,500

0.587%

Director, Anthony Henfrey waived his fees for the fourth quarter of 2012 as well as for the first three quarters of 2013.

Admission of the 663,821 new ordinary shares, ranking pari passu with the existing ordinary shares, is expected on 19 November 2013. Following this allotment the total issued share capital of the Company will increase to 146,884,071 ordinary shares with each share holding one voting right.

 

For further information please contact

Amphion InnovationsCharlie Morgan+1 212 210 6224

Novella Communications Tim Robertson / Ben Heath+44 020 3151 7008

Panmure Gordon Limited Freddy Crossley / Grishma Patel (Corporate Finance)Adam Pollock (Corporate Broking)+44 020 7886 2500

About Amphion Innovations plc

Amphion (LSE: AMP) builds shareholder value in emerging companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

On the web: www.amphionplc.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSQXLFFXFFXFBL
Date   Source Headline
5th Nov 20071:39 pmRNSResult of EGM
31st Oct 20075:49 pmRNSTotal Voting Rights-Amendment
31st Oct 20072:18 pmRNSTotal Voting Rights
29th Oct 20077:00 amRNSWellGen Series C Financing
12th Oct 20077:30 amRNSIssue of Equity
12th Sep 20077:01 amRNSInterim Results
28th Aug 200710:25 amRNSNotice of Results
22nd Aug 20077:01 amRNSChange of Adviser
16th Aug 20079:31 amRNSRe: AIM Rule 26
14th Aug 20077:00 amRNSFundraising
30th Jul 20077:01 amRNSRe: Series C Financing
12th Jul 20079:19 amRNSPatent Awarded
2nd Jul 20077:01 amRNSPlacing
7th Jun 20077:01 amRNSAGM Statement
21st May 20071:52 pmRNSRe: Symposium
21st May 20071:00 pmBUSApplied Genomics Paves the Way for Improved Prevention, Diagnosis, and Treatment of Disease
14th May 20074:25 pmBUSAmphion Innovations plc (LSE: ''AMP'') Announces First Annual Science & Business Symposium ''Building Market Value from the World of Genetics''
30th Apr 200711:02 amRNSDirector Shareholdings
11th Apr 200711:31 amRNSResearch Update
5th Apr 20071:00 pmBUSAmphion Innovations Partner Company Motif Biosciences Closes $1m Financing
5th Apr 20079:24 amRNSDirector/PDMR Shareholding
5th Apr 20077:01 amRNSRe: Series C Financing
23rd Mar 20072:42 pmBUSPort of Barbados Selects AXCESS to Provide Security Systems for the Cricket World Cup 2007
23rd Mar 20077:01 amRNSRe: Cricket World Cup
15th Mar 20077:01 amRNSFinal Results
26th Feb 20074:44 pmRNSNotice of Results
9th Feb 20077:00 amRNSRe: Financing
16th Jan 20073:25 pmBUSAmphion Innovations, plc Announces Creation of a Gulf-based Joint Venture
16th Jan 20073:19 pmBUSAmphion Innovations, plc Offers Trading Update
16th Jan 20077:01 amRNSJoint Venture
16th Jan 20077:00 amRNSTrading Update
8th Jan 20074:28 pmBUSAmphion Innovations plc Announces Fundraising
8th Jan 20071:08 pmRNSFundraising - Replacement
8th Jan 20077:00 amRNSFundraising
27th Nov 20063:04 pmBUSAmphion Innovations plc Acquires 35% Stake in Manchester Molecular Diagnostic Spin-out Company
27th Nov 20067:00 amRNSAcquires Stake in Company
13th Nov 20062:58 pmBUSAmphion Innovations plc Partner Company Supertron Acquires Spin Systems
13th Nov 20067:01 amRNSAcquisition
7th Nov 200610:24 amRNSRe: Partner Company
2nd Nov 20064:36 pmRNSDirector/PDMR Shareholding
24th Oct 20069:03 amRNSDirector/PDMR Shareholding
14th Sep 20067:00 amRNSWellGen CEO
12th Sep 20067:00 amRNSChange of Adviser
7th Sep 20067:01 amRNSInterim Results
22nd Aug 20064:00 pmRNSFireStar Software, Inc
17th Aug 20067:01 amRNSAdditional Shares Placed
9th Aug 20061:43 pmRNSIssue of Equity
24th Jul 20067:02 amRNSSeries C Financing
12th Jun 20064:58 pmRNSResult of AGM
8th Jun 20067:03 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.